About me
Dr. Smithey is the President, CEO and Co-founder of Serán BioScience. Over his 30-year career, he has led multiple research and development projects in a broad range of therapeutic areas. His work has led to the successful development of several novel medicines, including Tucatinib (Tukysa®) for the treatment of metastatic breast cancer. Dr. Smithey has extensive experience building entrepreneurial organizations that embrace a strong science and engineering approach to solving unmet need in drug development and biotechnology. Previously, Dr. Smithey led a team at Bend Research (now Lonza®) directed at research and development of novel pharmaceutical technologies, including the industry leading spray-dried dispersion technology that is broadly in use today. Subsequently, Dr. Smithey co-founded Agere Pharmaceuticals, a specialty CDMO, which was acquired by Patheon in 2015. He is an inventor in over 50 patent and patent applications in numerous technology and therapeutic areas. Dr. Smithey obtained a Ph.D. in Quantum Information and Optical Physics from the University of Oregon.
